Identifying the care needs of women living with HIV

The face of HIV has changed dramatically from the early days of the epidemic. Women now comprise more than half of all people living with HIV around the world. In Canada, an estimated 16,600 women are living with HIV/AIDS out of an estimated 71,300 HIV-positive Canadians. Women also represent an increasing proportion of annual positive HIV test reports, accounting for 23 per cent of the Canada total in 2011, nearly double the proportion observed in 1999 (12 per cent). Despite the changing epidemiology of HIV in Canada and globally, relatively limited research has focused on health issues specific to women living with HIV.

The increasing burden of HIV/AIDS on Canada’s female population is deeply concerning. We know that women face greater biological susceptibility to HIV. Women also face increased vulnerability due to prevailing social inequities including poverty, violence and racial marginalization.

Providing all people living with HIV with appropriate and timely treatment and care is critical to reduce HIV-related morbidity, mortality, and new HIV transmissions. However, women continue to face unique barriers to accessing treatment and care and show poorer outcomes. It’s therefore critical that we gain a better understanding of the needs of women living with HIV.

In an effort to acknowledge and address the gendered barriers to HIV treatment and care for Canadian women, our national team of researchers, clinicians, service providers, policy-makers, and women living with HIV collaborated to develop the Canadian HIV Women’s Sexual and Reproductive Health Cohort Study (CHIWOS). After two years of groundwork, CHIWOS was officially launched on October 1, 2013, the start of Women’s Health Awareness Month.

Angela Kaida
Hospital News
Read The Full Story

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below